Antioxidants | Free Full-Text | Targeting Pro-Oxidant Iron with Deferoxamine as a Treatment for Ischemic Stroke: Safety and Optimal Dose Selection in a Randomized Clinical Trial
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect
Diuretic Strategies in Patients with Acute Decompensated Heart Failure | NEJM
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet
Phase 2 randomized dose-finding sham-controlled trial in New York Heart... | Download Scientific Diagram
 "Johnson & Johnson Starts Two-Dose Trial Of Its Covid Candidate Vaccine In UK")
Johnson & Johnson Starts Two-Dose Trial Of Its Covid Candidate Vaccine In UK
Schema of the ARREST clinical trial. The initial dose level will be... | Download Scientific Diagram
UK launches booster dose trial of seven Covid-19 vaccines
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers: Molecular Therapy - Nucleic Acids
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial | Journal of the American College of Cardiology
فدوى الخريصي on Twitter: "The Dose Trial 💉 https://t.co/jnw6hmKvqr" / Twitter
How a COVID-19 vaccine trial error led to an unexpected discovery
Vaccines | Free Full-Text | The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design
DESTINY-Lung02 Trial | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Preliminary dose trial therapy. Presentation of the effect in reduction... | Download Scientific Diagram
Diuretic Strategies in Patients with Acute Decompensated Heart Failure | NEJM
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) - eClinicalMedicine
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial - The Lancet
Arvind Canchi (Conjeevaram)🇮🇳 on Twitter: "@nephondemand Waiting for the Low Dose TESTING Trial results. https://t.co/GUgym5AukK https://t.co/xKUsOkF9f7" / Twitter
High-Dose Biotin Fails in MS Trial | MedPage Today
The phases of preclinical and clinical trials
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
Diuretic Strategies in Patients with Acute Decompensated Heart Failure | NEJM
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial | JACC: Heart Failure
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022 | Business Wire
